Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre

INTRODUCTION: According to recent evidence about boosted protease inhibitors (PIs/r)-simplified regimens, the combination of 3TC and DRV/r 800/100 mg could represent a feasible option for optimizing antiretroviral therapy (ART) in treatment-experienced HIV+ patients. PATIENTS AND METHODS: We retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Borghetti, Alberto, Mondi, Annalisa, Piccoli, Benedetta, Gagliardini, Roberta, Lamonica, Silvia, Ciccarelli, Nicoletta, D'Avino, Alessandro, Pallavicini, Federico, Cauda, Roberto, De Luca, Andrea, Fabbiani, Massimiliano, Di Giambenedetto, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P285
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225243/
https://www.ncbi.nlm.nih.gov/pubmed/25397561
http://dx.doi.org/10.7448/IAS.17.4.19817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225243/
https://www.ncbi.nlm.nih.gov/pubmed/25397561
http://dx.doi.org/10.7448/IAS.17.4.19817

Ejemplares similares